M&A TRANSACTION · 2023
Cardiovascular Systems, Inc. acquired by Abbott
$850.0M· Medical Devices
Acquirer
Abbott
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$256.0M
EBITDA
-
Deal Value
$850.0M
What's your medical devices worth today?
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Context
This $850.0M acquisition of Cardiovascular Systems, Inc. by Abbott sits in the medical devices sub-vertical. Run a valuation for your own medical devices business via our Medical Devices valuation hub. Abbott is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from SEC Fairness Opinion - primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Compare your business to the Cardiovascular Systems, Inc. acquisition.
More on medical devices valuations
- Value a medical devices· run the calculator
- Medical Devices median multiples· real-deal benchmarks
- Who buys medical devices businesses?· active buyers
- Who acquired Owen Mumford Holdings?· buyer profile
- How to value a medical devices· long-form guide